Preuss H G, Goldin H
Kidney Int. 1983 Apr;23(4):635-42. doi: 10.1038/ki.1983.70.
Studies performed in the 1950's suggested that a circulating factor controlling renal growth (renotropin) could contribute to hypertension. However, no assay was available to prove its existence. Recently, different assays have been able to demonstrate the presence of a circulating renotropic factor following unilateral nephrectomy in rats. Therefore, we investigated certain aspects of renal growth in SHR, especially serum renotropic activity, and compared these with the same parameters in three strains of normotensive rats (SD, NWR, and WKY). Renal slice and renal DNA synthesis in response to unilateral nephrectomy were not unusual in SHR compared to other strains previously studied. Sera and renal extracts from young SHR following unilateral nephrectomy compared to sera and renal extracts from sham-operated SHR stimulated 3H-thymidine incorporation into the DNA of renal fragments. This pattern was similar to findings when sera and renal extracts from unilaterally nephrectomized SD were investigated, but the sera and extracts from SHR may have shown greater overall stimulation. Interestingly, a relative increase in renotropic activity was found in the serum of untouched SHR (11.1% +/- 1.7 (SEM), P less than 0.001) but not untouched NWR, SD, and WKY. The greatest renotropic activity in SHR was found at 6 to 16 weeks of age (13.5% +/- 2.1 (SEM), P less than 0.001). The previously reported activator found in renal tissue after unilateral nephrectomy was not found to be increased in untouched SHR. No studies were performed on SHR greater than 25 weeks of age. As a first approximation, our investigations are consistent with a previously hypothesis that renotropin may play some role in hypertension.
20世纪50年代进行的研究表明,一种控制肾脏生长的循环因子(肾生长素)可能与高血压有关。然而,当时没有检测方法能够证实其存在。最近,不同的检测方法已能够证明大鼠单侧肾切除术后存在循环促肾生长因子。因此,我们研究了自发性高血压大鼠(SHR)肾脏生长的某些方面,尤其是血清促肾生长活性,并将这些与三种正常血压大鼠品系(SD、NWR和WKY)的相同参数进行了比较。与之前研究的其他品系相比,SHR对单侧肾切除的肾切片和肾DNA合成并无异常。与假手术的SHR的血清和肾提取物相比,单侧肾切除的年轻SHR的血清和肾提取物刺激了3H-胸腺嘧啶核苷掺入肾片段的DNA中。这种模式与研究单侧肾切除的SD大鼠的血清和肾提取物时的发现相似,但SHR的血清和提取物可能总体上显示出更大的刺激作用。有趣的是,在未处理的SHR血清中发现促肾生长活性相对增加(11.1%±1.7(标准误),P<0.001),但未处理的NWR、SD和WKY大鼠血清中未发现。SHR在6至16周龄时促肾生长活性最高(13.5%±2.1(标准误),P<0.0化)。在未处理的SHR中未发现单侧肾切除后在肾组织中发现的先前报道的激活剂增加。未对大于25周龄的SHR进行研究。初步来看,我们的研究结果与之前的假设一致,即肾生长素可能在高血压中起一定作用。